Related Experiment Video
Updated: Jul 25, 2026
10:33
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
11.0K
Methylation Analysis of Colitis-Associated Colorectal Carcinomas
Franziska Haumaier1, Theresa Dregelies1, William Sterlacci1
1Institute for Pathology, Friedrich-Alexander University Erlangen-Nürnberg, Klinikum Bayreuth, D-95445 Bayreuth, Germany.
Discovery Medicine
|July 26, 2024
Summary
Distinguishing colitis-associated carcinoma (CAC) from sporadic colorectal cancer (sCRC) is challenging. Researchers identified three key methylation sites that can differentiate between CAC and sCRC with 94.5% accuracy.
Area of Science:
- Gastroenterology
- Oncology
- Epigenetics
Background:
- Ulcerative colitis (UC) patients face an elevated risk of colitis-associated carcinoma (CAC).
- Differentiating CAC from sporadic colorectal cancer (sCRC) is diagnostically challenging, often impossible via histology alone.
- Accurate distinction is vital for appropriate patient management, treatment, and follow-up.
Purpose of the Study:
- To develop a reliable diagnostic method for distinguishing between CAC and sCRC.
- To identify distinct epigenetic patterns, specifically DNA methylation, differentiating these two carcinoma types.
Main Methods:
- Analyzed over 850,000 methylation hotspots across 96 patients, including those with sCRC, CAC, normal colon tissue, and UC without neoplasia.
- Applied extensive filtering to identify methylation sites crucial for differentiating CAC from sCRC.
- Defined methylation limit values for classifying samples as either CAC or sCRC based on identified sites.
Main Results:
- Identified three specific methylation sites capable of distinguishing between CAC and sCRC.
- Achieved a 94.5% accuracy rate in correctly assigning samples to either CAC or sCRC by combining the analysis of these three methylation sites.
- Established methylation limit values for accurate sample classification.
Conclusions:
- The three identified methylation sites show significant promise as diagnostic markers for differentiating CAC from sCRC.
- The study emphasizes that while these methylation markers are powerful, the final diagnosis should integrate histomorphological analysis.
